La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:La Jolla Institute for Allergy & Immunology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9345
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and asthma, cancer, diabetes, infectious disease, inflammation biology, microbiology and immunology, and RNAi research. LIAI also offers autoimmune research on rheumatoid arthritis, type 1 diabetes, multiple sclerosis and Crohn’s disease, among others. The institute operates through various research centers located across the US. LIAI is headquartered in La Jolla, California, the US.

La Jolla Institute for Allergy & Immunology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Licensing Agreements 13
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
Equity Offering 14
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology – Key Competitors 15
La Jolla Institute for Allergy & Immunology – Key Employees 16
La Jolla Institute for Allergy & Immunology – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 12, 2018: LJI Researchers are One Step Closer to an Effective Anti-Atherosclerosis Vaccine 18
Product News 19
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 19
Jun 20, 2017: San Diego team tests best delivery mode for potential HIV vaccine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Key Facts 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology, Key Competitors 15
La Jolla Institute for Allergy & Immunology, Key Employees 16

List of Figures
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gebr. Heinemann SE & Co. KG:戦略・SWOT・企業財務分析
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cornerstone OnDemand, Inc.:企業のM&A・事業提携・投資動向
    Cornerstone OnDemand, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cornerstone OnDemand, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Electricity Generating Authority of Thailand:企業の戦略・SWOT・財務分析
    Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report Summary Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Kobayashi Pharmaceutical Co Ltd (4967):医療機器:M&Aディール及び事業提携情報
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • African Phoenix Investments Limited:企業の戦略・SWOT・財務情報
    African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Under Armour Inc (UAA):企業の財務・戦略的SWOT分析
    Under Armour Inc (UAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Intercept Energy Services Inc (IES):石油・ガス:M&Aディール及び事業提携情報
    Summary Intercept Energy Services Inc (Intercept Energy), formerly Global Green Matrix Corp is an oilfield service firm that offers water heating services. The firm provides services such as oilfield services, energy extraction and related services, frac water heating, oil sands processing, and oilf …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company provides products such as proprietary software and services, third party software and services; and hardware and infrastructure. Asseco also offers services that include cloud services …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Amyris Inc (AMRS):企業の財務・戦略的SWOT分析
    Summary Amyris Inc (Amyris) formerly Amyris Biotechnologies Inc, is a healthcare product manufacturer that offers integrated renewable products. The company provides alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty product …
  • Sky Ltd:企業の戦略的SWOT分析
    Sky Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • MicroVention Inc:製品パイプライン分析
    Summary MicroVention Inc (MicroVention), a subsidiary of Terumo Corp is a medical device company that develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. The company offers products such as platinum coils, hydrogel coils, delivery and det …
  • GfK SE:企業の戦略・SWOT・財務情報
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • iCAD Inc (ICAD):医療機器:M&Aディール及び事業提携情報
    Summary iCAD Inc (iCAD) develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD products find application in detectio …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆